Table 3.
Pharmaceutical Costs
| Antipsychotic | PrePGx (€) | PostPGx (€) | Variation (%) | PrePGx (€/Patient) | PostPGx (€/Patient) | Variation (%) |
|---|---|---|---|---|---|---|
| Olanzapine | 38,754.79 | 18,438.89 | −51.74 | 717.68 | 472.79 | −34.12 |
| Aripiprazole | 62,296.64 | 84,476.43 | +20.16 | 1271.36 | 1919.92 | +51.01 |
| Risperidone | 27,674.40 | 354.12 | −98.70 | 588.82 | 177.06 | −69.99 |
| Amisulpride | 4820.19 | 1222.15 | −74.65 | 370.78 | 174.59 | −52.91 |
| Clozapine | 10,398.30 | 5178.44 | −34.90 | 273.64 | 207.14 | −24.30 |
| Paliperidone | 113,284.51 | 297,452.8 | +162.57 | 2832.11 | 3913.85 | +38.20 |
| Quetiapine | 242,287.37 | 14,289.75 | −94.10 | 3727.50 | 752.09 | −79.82 |
| Asenapine | 14,289.75 | 9526.50 | −33.33 | 752.09 | 635.10 | −15.56 |
| Anual Total | 513,805.94 | 462,618.92 | −9.96 | 2886.55 | 2598.98 | −9.96 |
| Triennium Total | 1,798,320.80 | 1,619,166.20 | −9.96 | 10,102.93 | 9096.44 | −9.96 |
Abbreviations: PrePGx, pharmaceutical cost associated with each drug before most of the population was pharmacogenotyped (2013–2016); PostPGx, pharmaceutical cost associated with each drug after most of the population was pharmacogenotyped (2016–2019).